| PERIOD ENDING | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | 31-Oct-08 | | Total Revenue | 57,382 | 54,891 | 59,180 | 64,450 | | Cost of Revenue | 28,628 | 25,209 | 29,684 | 29,885 | | | Gross Profit | 28,754 | 29,682 | 29,496 | 34,565 | | | Operating Expenses | | Research Development | 14,358 | 15,066 | 15,459 | 16,553 | | Selling General and Administrative | 17,528 | 18,919 | 19,589 | 19,230 | | Non Recurring |
-
|
-
|
-
| (87,811) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (3,132) | (4,303) | (5,552) | 86,593 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 214 | 190 | 423 | 17,213 | | Earnings Before Interest And Taxes | (2,918) | (4,113) | (5,129) | 103,806 | | Interest Expense |
-
|
-
| 278 | 94 | | Income Before Tax | (2,918) | (4,113) | (5,407) | 103,712 | | Income Tax Expense | 19 | 16 | (1,840) | 3,132 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,937) | (4,129) | (3,567) | 100,580 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,937) | (4,129) | (3,567) | 100,580 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,937) | ($4,129) | ($3,567) | $100,580 |
|
0.11% Nasdaq 
0.24%
Income Statement
